The role of the implantable cardiac defibrillator in the management

Olaf Hedrich, Gianfranco Buja, Domenico Corrado, Mark S. Link, Thomas Wichter, N. A Mark Estes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

Original languageEnglish (US)
Title of host publicationArrhythmogenic RV Cardiomyopathy/Dysplasia
Subtitle of host publicationRecent Advances
PublisherSpringer Milan
Pages189-197
Number of pages9
ISBN (Print)9788847004894
DOIs
StatePublished - Dec 1 2007

Fingerprint

Implantable Defibrillators
Arrhythmogenic Right Ventricular Dysplasia
Sudden Cardiac Death
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hedrich, O., Buja, G., Corrado, D., Link, M. S., Wichter, T., & Estes, N. A. M. (2007). The role of the implantable cardiac defibrillator in the management. In Arrhythmogenic RV Cardiomyopathy/Dysplasia: Recent Advances (pp. 189-197). Springer Milan. https://doi.org/10.1007/978-88-470-0490-0_21

The role of the implantable cardiac defibrillator in the management. / Hedrich, Olaf; Buja, Gianfranco; Corrado, Domenico; Link, Mark S.; Wichter, Thomas; Estes, N. A Mark.

Arrhythmogenic RV Cardiomyopathy/Dysplasia: Recent Advances. Springer Milan, 2007. p. 189-197.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hedrich, O, Buja, G, Corrado, D, Link, MS, Wichter, T & Estes, NAM 2007, The role of the implantable cardiac defibrillator in the management. in Arrhythmogenic RV Cardiomyopathy/Dysplasia: Recent Advances. Springer Milan, pp. 189-197. https://doi.org/10.1007/978-88-470-0490-0_21
Hedrich O, Buja G, Corrado D, Link MS, Wichter T, Estes NAM. The role of the implantable cardiac defibrillator in the management. In Arrhythmogenic RV Cardiomyopathy/Dysplasia: Recent Advances. Springer Milan. 2007. p. 189-197 https://doi.org/10.1007/978-88-470-0490-0_21
Hedrich, Olaf ; Buja, Gianfranco ; Corrado, Domenico ; Link, Mark S. ; Wichter, Thomas ; Estes, N. A Mark. / The role of the implantable cardiac defibrillator in the management. Arrhythmogenic RV Cardiomyopathy/Dysplasia: Recent Advances. Springer Milan, 2007. pp. 189-197
@inbook{d7c7bbb1dd644713b238299a78a79e4e,
title = "The role of the implantable cardiac defibrillator in the management",
abstract = "The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.",
author = "Olaf Hedrich and Gianfranco Buja and Domenico Corrado and Link, {Mark S.} and Thomas Wichter and Estes, {N. A Mark}",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/978-88-470-0490-0_21",
language = "English (US)",
isbn = "9788847004894",
pages = "189--197",
booktitle = "Arrhythmogenic RV Cardiomyopathy/Dysplasia",
publisher = "Springer Milan",

}

TY - CHAP

T1 - The role of the implantable cardiac defibrillator in the management

AU - Hedrich, Olaf

AU - Buja, Gianfranco

AU - Corrado, Domenico

AU - Link, Mark S.

AU - Wichter, Thomas

AU - Estes, N. A Mark

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

AB - The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

UR - http://www.scopus.com/inward/record.url?scp=84895227474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895227474&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-0490-0_21

DO - 10.1007/978-88-470-0490-0_21

M3 - Chapter

AN - SCOPUS:84895227474

SN - 9788847004894

SP - 189

EP - 197

BT - Arrhythmogenic RV Cardiomyopathy/Dysplasia

PB - Springer Milan

ER -